Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-08-28
2007-08-28
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S365000, C514S569000, C514S568000
Reexamination Certificate
active
10963848
ABSTRACT:
The present invention relates to compositions comprising telmesteine, glycyrrhetinic acid, and a proanthocyanidin, as well as methods for using such compositions in the treatment of an inflammatory condition of the skin including, but not limited to, atopic dermatitis(eczema), allergic contact dermatitis, seborrheic dermatitis, psoriasis,xerosisand atopia, as well as treatment of an inflammatory condition of mucosae and of an inflammatory condition in the eye. The present invention also relates to compositions comprising a proanthocyanidin, glycyrrhetinic acid and telmesteine, as well as methods for using such compositions in the treatment of an inflammatory condition of the skin including, but not limited to, atopic dermatitis, allergic contact dermatitis, seborrheic dermatitis, radiation dermatitis, psoriasis,xerosisand atopia, as well as treatment of an inflammatory condition of mucosae and of an inflammatory condition in the eye.
REFERENCES:
patent: 4874774 (1989-10-01), Ushimaru et al.
patent: 4963527 (1990-10-01), Bombardelli et al.
patent: 5422118 (1995-06-01), Brown et al.
patent: 5470874 (1995-11-01), Lerner
patent: 5945409 (1999-08-01), Crandall
patent: 0694305 (1996-01-01), None
patent: 1215469 (1990-02-01), None
patent: 6336421 (1994-12-01), None
Gianotti, A. “Telemestein and variations in blood concentrations of lipoprotein A” La Clinica terapeutica (1994) vol. 145, No. 10, pp. 283-385.
Vinson et al., “Beneficial effects of a novel IH636 grape seed proanthocyanidin extract and a niacin-bound chromium in a hamster atherosclerosis model” Molecular and Cellular Biochemistry (2002) vol. 240, pp. 99-103.
Zakirov et al., “The hypolipidemic and antiatherosclerotic properties of the ammonium salt of glycyrrhetic acid and of 18-dehydroglycyrrhetic acid” Eksperimental'naia i klinicheskaia farmakologiia (1996) vol. 59, No. 5, pp. 53-55.
Nicolosi et al. “Vitamin E Reduces Plasma Low Density Lipoprotein Cholesterol, LDL Oxidation, and Early Aortic Atherosclerosis Compared with Black Tea in Hypercholesterolemic Hamsters” Nutrition Research (1999) vol. 19, No. 8, pp. 1201-1214.
Kadir et al., “Alpha-Bisabolol, a possible safe penetration enhancer for dermal and transdermal therapeutics” International Journal of Pharmaceutics (1991) vol. 70, pp. 87-94.
Remington: The Science and Practice of Pharmacy, 20thEdition, (2000) Published by the Philadelphia College of Pharmacy and Science, Edited by Alfonso R. Gennaro et al., pp. 836-844 and 917-918.
Ashcroft et al.,J. of Clin. Pharm. and Therap., 25:1-10 (2000).
Greaves,New England J. of Medicine, 332:581-588 (1995).
Langer,Science, 249:1527-1533 (1990).
Nevitt et al.,British J. of Dermatology, 135:533-537 (1996).
Roenigk et al.,J. of the Am. Acad. of Dermatology, 1:145-156 (1988).
Stern,Cancer, 73:2759-2764 (1994).
Stern,Dermatol. Clin., 13:717-722 (1995).
Treat et al., Liposomes in the Therapy of Infectious Disease and Cancer, Lopez-Berestein and Fidler (eds.) Liss, New York, 353-365 (1989).
Ciattini Roberto
Mastrodonato Marco
Jiang Shaojia Anna
Marshall & Gerstein & Borun LLP
Olson Eric
Sinclair Pharmaceuticals, Ltd.
LandOfFree
Compositions and methods for the treatment of inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the treatment of inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the treatment of inflammatory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3870443